The global infant incubator market is predicted to grow at a CAGR of 7.2% from 2024 to 2029. The market size is anticipated to be valued at USD 566.01 million by 2029 from USD 399.87 million in 2024.
The Infant Incubator is a biomedical device that provides oxygen, humidity, and warmth to the newborn in a controlled environment. The infant incubator comprises an enclosed chamber with a bit of mattress on top, covered with a rigid plastic cover. This chamber protects the baby from dust, noise, and infection. Because of the high percentage of preterm births, infant incubators are frequently utilized worldwide. For example, around 15 million preterm babies are born each year across the globe. This demonstrates the significant need for infant incubators around the world. In Chicago, the Robert H. Lurie Children's Hospital developed wireless sensors and biosensors to replace incubators' wires to monitor vital signs connected to mother-child interaction.
The infant incubator market is growing and expected to attain a higher CAGR in the coming years due to recent developments in product innovation, research studies and global indicators. As per the World Health Organization, prematurity is the primary reason for the death of children under 5 and is a pressing public health crisis and it is projected that approximately 13.4 million infants are born prematurely i.e. before 37 weeks of pregnancy but on the other, an even greater population of infants have underweight births of below 2.5 kg during childbirth. So, the WHO introduced two new materials to assist broader acceptance of kangaroo mother care (KMC). These materials are global position paper and implementation strategy. Hence, the rising incidence of premature births and infant mortality rate is fuelling the market forward. Also, the latest developments in increasing energy storage and the application of phase change materials (PCMs) for thermal power backup are believed to drive the infant incubator market. According to December 2023 research, the PCMs have the capability to sustain and manage a temperature above 32 degrees calicoes for more than 8 hours.
As per the reports of the WHO, it is stated that about 15 million premature births happen every year across the globe. It also says that prematurity is one of the significant contributors to infant mortality. Also, the market for new-born incubators is expected to develop due to the use of new-born incubators having improved preterm infant survival rates and reduced neonatal hypothermia.
Technological advancements in newborn incubators have emerged from research and development efforts. Manufacturers of new-born incubators consider hospitals to be important places for selling their goods since they aid in developing brand image and the expansion of product reach. Furthermore, increasing investments by the government to reduce mortality and infant mortality rates have enabled the hospitals to focus on expanding productivity by adopting advanced and innovative medical devices such as Neonatal incubators, which is expected to boost the market growth.
The COVID-19 pandemic is one of the significant factors for the market to grow, as several infants are affected by the virus across the globe. Improving the healthcare industry's infrastructure and installing NICU units in almost every hospital is lucratively anticipated to fuel the market's demand. Growing support from government organizations to provide excellent services to patients positively influences the market's growth. In addition, infant incubators help increase the baby's survival rate in critical conditions, driving the market's growth rate. Ongoing research on developing innovative devices in favor of the end-users in the medical field is set to create growth opportunities. As a result, the medical sector's penetration of new technological developments is gaining traction over market growth.
Lack of awareness in rural areas is hampering the growth of the global infant incubator market to a limited extent. However, the high cost of these devices is impeding the demand of the global infant incubator market. Lack of proper equipment in rural areas is also one factor limiting the growth rate of the infant incubator market. In addition, the negligence of the technical members in monitoring the devices is slowly hindering the demand of this market. Furthermore, inadequate reimbursement policies and a lack of knowledge of these devices' benefits are challenging for market players. The government's strict rules and regulations in approving innovative devices also degrade the infant incubator market's growth rate.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product, Application, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leader Profiled |
GE Healthcare, Novos Medical Systems, Atom Medical Corporation, Ningbo David Medical Device Co., Ltd, Natus Medical Incorporated, Fanem Ltd, Cobams Srl, AVI Healthcare Private Limited, Gammer International, and Ardo. |
The neonatal intensive care unit incubator segment held the leading share in the global infant incubator market in 2023 and the lead of the segment is expected to continue throughout the forecast period due to the growing prevalence of the hospitals' advanced technological equipment.
The transport infant incubator segment is expected to register the highest growth rate in the foreseen years. Increasing medical campaigns with support from public and private organizations propel the market's growth rate.
The neonatal hypothermia segment is predicted to dominate the global infant incubator market during the forecast period due to rising incidences of premature babies. The lower birth weight segment is positioned second in leading the prominent share of the market. Increasing investments in the healthcare sector to improve infrastructure is propelling the growth rate of this segment. In addition, genetic defects and other segments are at a steady growth rate during the forecast period.
North America leads the global market during the forecast period due to advanced medical care and the European market. Asia Pacific is the most lucrative market in the world, with the highest CAGR. The rise in premature babies is a substantial factor for growth in the North American region. The adoption of the latest technologies is additionally influencing the growth of the market positively. The U.S. held most of the North American market share in 2020. Growing disposable income and the need for quality treatment procedures are escalating the demand for this market. The Canadian infant incubator market is estimated to grow at a prominent CAGR during the forecast period due to constant economic growth.
Europe is expected to register a significant share in the global market during the forecast period. Escalating healthcare expenditure and the rise in the economy from the past few years are expected to favor the European market. As a result, Germany and the U.K. are expected to occupy a significant share of the European market during the forecast period.
Asia-Pacific is forecasted to register the fastest growth rate among all regions in the global market. A growing number of healthcare centers and an increasing patient pool are two factors elevating its growth rate. In addition, India and China are expected to showcase a promising CAGR during the forecast period.
Some of the notable participants playing a dominating role in the global infant incubator market profiled in this report are GE Healthcare, Novos Medical Systems, Atom Medical Corporation, Ningbo David Medical Device Co., Ltd, Natus Medical Incorporated, Fanem Ltd, Cobams Srl, AVI Healthcare Private Limited, Gammer International, and Ardo.
By Product
By Application
By Region
Frequently Asked Questions
The global infant incubator market was valued at USD 373.02 million in 2023.
The global infant incubator market is anticipated to value USD 528.08 million by 2028.
The North American region is anticipated to play the leading role in the global infant incubator market during the forecast period.
GE Healthcare, Novos Medical Systems, Atom Medical Corporation, Ningbo David Medical Device Co., Ltd, Natus Medical Incorporated, Fanem Ltd, Cobams Srl, AVI Healthcare Private Limited, Gammer International, and Ardo are a few of the leading companies in the infant incubator market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region